Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

<h4>Background</h4>Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled intervention trial was conducted in a general population of South Africa to test this hypothesis.<h4>Methods and findings</h4>A tot...

Full description

Bibliographic Details
Main Authors: Bertran Auvert, Dirk Taljaard, Emmanuel Lagarde, Joëlle Sobngwi-Tambekou, Rémi Sitta, Adrian Puren
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2005-11-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.0020298
id doaj-92f26daa8d67452895aebaf060621810
record_format Article
spelling doaj-92f26daa8d67452895aebaf0606218102021-04-21T18:19:35ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762005-11-01211e29810.1371/journal.pmed.0020298Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.Bertran AuvertDirk TaljaardEmmanuel LagardeJoëlle Sobngwi-TambekouRémi SittaAdrian Puren<h4>Background</h4>Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled intervention trial was conducted in a general population of South Africa to test this hypothesis.<h4>Methods and findings</h4>A total of 3,274 uncircumcised men, aged 18-24 y, were randomized to a control or an intervention group with follow-up visits at months 3, 12, and 21. Male circumcision was offered to the intervention group immediately after randomization and to the control group at the end of the follow-up. The grouped censored data were analyzed in intention-to-treat, univariate and multivariate, analyses, using piecewise exponential, proportional hazards models. Rate ratios (RR) of HIV incidence were determined with 95% CI. Protection against HIV infection was calculated as 1 - RR. The trial was stopped at the interim analysis, and the mean (interquartile range) follow-up was 18.1 mo (13.0-21.0) when the data were analyzed. There were 20 HIV infections (incidence rate = 0.85 per 100 person-years) in the intervention group and 49 (2.1 per 100 person-years) in the control group, corresponding to an RR of 0.40 (95% CI: 0.24%-0.68%; p < 0.001). This RR corresponds to a protection of 60% (95% CI: 32%-76%). When controlling for behavioural factors, including sexual behaviour that increased slightly in the intervention group, condom use, and health-seeking behaviour, the protection was of 61% (95% CI: 34%-77%).<h4>Conclusion</h4>Male circumcision provides a degree of protection against acquiring HIV infection, equivalent to what a vaccine of high efficacy would have achieved. Male circumcision may provide an important way of reducing the spread of HIV infection in sub-Saharan Africa. (Preliminary and partial results were presented at the International AIDS Society 2005 Conference, on 26 July 2005, in Rio de Janeiro, Brazil.).https://doi.org/10.1371/journal.pmed.0020298
collection DOAJ
language English
format Article
sources DOAJ
author Bertran Auvert
Dirk Taljaard
Emmanuel Lagarde
Joëlle Sobngwi-Tambekou
Rémi Sitta
Adrian Puren
spellingShingle Bertran Auvert
Dirk Taljaard
Emmanuel Lagarde
Joëlle Sobngwi-Tambekou
Rémi Sitta
Adrian Puren
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
PLoS Medicine
author_facet Bertran Auvert
Dirk Taljaard
Emmanuel Lagarde
Joëlle Sobngwi-Tambekou
Rémi Sitta
Adrian Puren
author_sort Bertran Auvert
title Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
title_short Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
title_full Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
title_fullStr Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
title_full_unstemmed Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
title_sort randomized, controlled intervention trial of male circumcision for reduction of hiv infection risk: the anrs 1265 trial.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2005-11-01
description <h4>Background</h4>Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled intervention trial was conducted in a general population of South Africa to test this hypothesis.<h4>Methods and findings</h4>A total of 3,274 uncircumcised men, aged 18-24 y, were randomized to a control or an intervention group with follow-up visits at months 3, 12, and 21. Male circumcision was offered to the intervention group immediately after randomization and to the control group at the end of the follow-up. The grouped censored data were analyzed in intention-to-treat, univariate and multivariate, analyses, using piecewise exponential, proportional hazards models. Rate ratios (RR) of HIV incidence were determined with 95% CI. Protection against HIV infection was calculated as 1 - RR. The trial was stopped at the interim analysis, and the mean (interquartile range) follow-up was 18.1 mo (13.0-21.0) when the data were analyzed. There were 20 HIV infections (incidence rate = 0.85 per 100 person-years) in the intervention group and 49 (2.1 per 100 person-years) in the control group, corresponding to an RR of 0.40 (95% CI: 0.24%-0.68%; p < 0.001). This RR corresponds to a protection of 60% (95% CI: 32%-76%). When controlling for behavioural factors, including sexual behaviour that increased slightly in the intervention group, condom use, and health-seeking behaviour, the protection was of 61% (95% CI: 34%-77%).<h4>Conclusion</h4>Male circumcision provides a degree of protection against acquiring HIV infection, equivalent to what a vaccine of high efficacy would have achieved. Male circumcision may provide an important way of reducing the spread of HIV infection in sub-Saharan Africa. (Preliminary and partial results were presented at the International AIDS Society 2005 Conference, on 26 July 2005, in Rio de Janeiro, Brazil.).
url https://doi.org/10.1371/journal.pmed.0020298
work_keys_str_mv AT bertranauvert randomizedcontrolledinterventiontrialofmalecircumcisionforreductionofhivinfectionrisktheanrs1265trial
AT dirktaljaard randomizedcontrolledinterventiontrialofmalecircumcisionforreductionofhivinfectionrisktheanrs1265trial
AT emmanuellagarde randomizedcontrolledinterventiontrialofmalecircumcisionforreductionofhivinfectionrisktheanrs1265trial
AT joellesobngwitambekou randomizedcontrolledinterventiontrialofmalecircumcisionforreductionofhivinfectionrisktheanrs1265trial
AT remisitta randomizedcontrolledinterventiontrialofmalecircumcisionforreductionofhivinfectionrisktheanrs1265trial
AT adrianpuren randomizedcontrolledinterventiontrialofmalecircumcisionforreductionofhivinfectionrisktheanrs1265trial
_version_ 1714665047212425216